Kien Nguyen Tran, Hoa Nguyen Phuong, Tung Ha Huu, Van den Broeck Kris, Wens Johan
Family Medicine Department, Hanoi Medical University, Hanoi, Vietnam.
Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
J Diabetes Res. 2025 Mar 28;2025:6992121. doi: 10.1155/jdr/6992121. eCollection 2025.
This study investigates the impact of Type 2 diabetes mellitus (T2DM) and depressive symptoms on the health-related quality of life (HRQoL) among patients at the Agricultural General Hospital in Hanoi, Vietnam. The research explores the interconnections between chronic physical conditions and mental health within a resource-constrained healthcare environment. A cross-sectional survey was conducted with 516 T2DM patients using the SF-36 to assess HRQoL and the PHQ-9 to measure depressive symptoms. The study examined the prevalence of depressive symptoms and their correlation with various HRQoL components. Among the participants, 45.2% exhibited depressive symptoms from mild to severe levels. Significant disparities in HRQoL scores were observed, particularly in physical composite and overall quality of life scores between T2DM with and without depressive symptoms. Statistical analysis highlighted that depressive symptoms significantly diminish HRQoL, with the PHQ-9 scores serving as a robust predictor. The findings underscore the critical need for integrated care approaches that include mental health support for T2DM patients. Routine screening for depressive symptoms should be a component of diabetes management protocols to improve overall patient outcomes. Further longitudinal research is needed to confirm these findings and develop effective interventions.
本研究调查了越南河内农业综合医院患者中2型糖尿病(T2DM)和抑郁症状对健康相关生活质量(HRQoL)的影响。该研究探讨了在资源有限的医疗环境中慢性身体状况与心理健康之间的相互联系。对516名T2DM患者进行了横断面调查,使用SF-36评估HRQoL,使用PHQ-9测量抑郁症状。该研究调查了抑郁症状的患病率及其与各种HRQoL组成部分的相关性。在参与者中,45.2%表现出从轻度到重度的抑郁症状。观察到HRQoL得分存在显著差异,特别是在有和没有抑郁症状的T2DM患者的身体综合得分和总体生活质量得分方面。统计分析强调,抑郁症状会显著降低HRQoL,PHQ-9得分是一个有力的预测指标。研究结果强调了综合护理方法的迫切需求,其中包括为T2DM患者提供心理健康支持。对抑郁症状进行常规筛查应成为糖尿病管理方案的一部分,以改善患者的总体预后。需要进一步的纵向研究来证实这些发现并制定有效的干预措施。